MLYS
NASDAQ · Biotechnology
Mineralys Therapeutics Inc
$29.26
+2.61 (+9.79%)
Performance
1D
—
1W
—
1M
—
3M
-7.81%
6M
-34.25%
1Y
+99.73%
YTD
-18.06%
Open$27.75
Previous Close$26.65
Day High$29.64
Day Low$27.48
52W High$47.65
52W Low$12.59
Volume—
Avg Volume1.12M
Market Cap2.42B
P/E Ratio—
EPS$-2.38
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$33.44
Below
SMA 200
$27.93
Above
RSI (14)
35
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
15 analysts
Price Target
+218.5% upside
Current
$29.26
$29.26
Target
$93.19
$93.19
$50.31
$93.19 avg
$121.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 422.84M | 383.53M | 332.94M |
| Net Income | 48.98M | 43.51M | 33.06M |
| Profit Margin | 11.6% | 11.3% | 9.9% |
| EBITDA | 63.20M | 67.45M | 57.44M |
| Free Cash Flow | 26.85M | 26.46M | 31.26M |
| Rev Growth | +5.2% | +16.0% | +2.3% |
| Debt/Equity | 0.29 | 0.28 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |